Literature DB >> 1585397

Comparative absorption of atropine from a metered-dose inhaler and an intramuscular injection.

C R Kehe1, K C Lasseter, N C Miller, K A Wick, E C Shamblen, B P Ekholm, J H Sandahl, S F Chang, M B Goldlust, D C Kvam.   

Abstract

The inhalation of atropine sulfate from a pressurized metered-dose inhaler was investigated in a nonrandomized four-period rising-dose study. Eight healthy, nonsmoking subjects received 1.7, 3.4, and 5.2 mg of atropine sulfate by inhalation and 1.67 mg of atropine free base (equivalent to 2 mg of atropine sulfate) by intramuscular (i.m.) injection. Serum atropine sulfate concentrations were measured over a 24-h period by gas chromatography/mass spectrometry. Mean serum concentrations increased nonproportionally as the inhaled dose increased. Mean peak concentrations were 4.9, 6.1, and 7.9 ng/ml for the inhaled doses and 8.4 ng/ml for the i.m. dose. Typical anticholinergic effects were seen after all doses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1585397     DOI: 10.1097/00007691-199204000-00009

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  1 in total

1.  Systemic delivery of atropine sulfate by the MicroDose Dry-Powder Inhaler.

Authors:  T E Corcoran; R Venkataramanan; R M Hoffman; M P George; A Petrov; T Richards; S Zhang; J Choi; Y Y Gao; C D Oakum; R O Cook; M Donahoe
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-06-12       Impact factor: 2.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.